Accenture (ACN) Director Granted 7,361 RSUs at $247.57 鈥� Form 4

Q: What did Paula A. Price report on the Form 4 for ACN?

The Form 4 reports a grant of 7,361 Class A ordinary shares as RSUs to Paula A. Price on 08/15/2025 , with a reported price of $247.57 .

Q: Why were the RSUs granted to the reporting person?

The filing states the RSUs were granted pursuant to anti-dilution provisions of previously granted RSU awards to reflect Accenture's payment of a cash dividend.

Q: What ownership does the Form 4 show after the transaction?

After the reported transaction, the Form 4 shows 7,361 shares beneficially owned by the reporting person in direct form.

Q: When was the Form 4 signed and by whom?

The Form 4 bears the signature of Danika Haueisen, Attorney-in-Fact for Paula A. Price dated 08/18/2025 .

Q: Does this Form 4 indicate a sale or open-market trade?

No. The transaction code is "A" indicating an acquisition (grant) of RSUs, not a sale or open-market transaction.

[Form 4] Accenture PLC Insider Trading Activity

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Paula A. Price, a director of Accenture plc (ACN), was granted 7,361 Class A ordinary shares as Restricted Share Units (RSUs) on 08/15/2025 at an indicated price of $247.57 per share. The Form 4 reports the acquisition code "A" and explains these RSUs were issued pursuant to anti-dilution provisions of previously granted awards to reflect Accenture's cash dividend. After the grant, Ms. Price beneficially owns 7,361 shares in direct form. The filing was signed by an attorney-in-fact on 08/18/2025.

Insights

TL;DR: Insider received dividend-related RSUs, a routine compensatory adjustment with limited market impact.

The reported transaction is an administrative grant of 7,361 RSUs to correct for dilution from a cash dividend, not a discretionary open-market purchase or sale. Such anti-dilution allocations preserve the economic value of prior awards for the director and do not necessarily indicate a change in insider sentiment. The size of the grant should be evaluated against Ms. Price's existing holdings and Accenture's overall share count to judge materiality, but on its face this is a routine, compensatory adjustment.

TL;DR: Transaction reflects standard plan mechanics; it raises no immediate governance red flags.

The Form 4 discloses an RSU issuance under anti-dilution terms to reflect a cash dividend, which is a common feature of long-term equity awards. The filing is timely and properly executed by an attorney-in-fact. There is no indication of acceleration, special one-off awards, or unusual pricing mechanics in the disclosure provided.

08/18/2025 - 04:19 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Price Paula A

(Last)

(First)

(Middle)

C/O ACCENTURE

500 W. MADISON STREET

(Street)

CHICAGO

60661

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Accenture plc [ ACN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A ordinary shares	08/15/2025		A		6⁽¹⁾	A	$247.57	7,361	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend.

Remarks:

	/s/ Danika Haueisen, Attorney-in-Fact for Paula A. Price	08/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

What did Paula A. Price report on the Form 4 for ACN?

The Form 4 reports a grant of 7,361 Class A ordinary shares as RSUs to Paula A. Price on 08/15/2025, with a reported price of $247.57.

Why were the RSUs granted to the reporting person?

The filing states the RSUs were granted pursuant to anti-dilution provisions of previously granted RSU awards to reflect Accenture's payment of a cash dividend.

What ownership does the Form 4 show after the transaction?

After the reported transaction, the Form 4 shows 7,361 shares beneficially owned by the reporting person in direct form.

When was the Form 4 signed and by whom?

The Form 4 bears the signature of Danika Haueisen, Attorney-in-Fact for Paula A. Price dated 08/18/2025.

Does this Form 4 indicate a sale or open-market trade?

No. The transaction code is "A" indicating an acquisition (grant) of RSUs, not a sale or open-market transaction.

AG真人官方

[Form 4] Accenture PLC Insider Trading Activity

Insights

FAQ

What did Paula A. Price report on the Form 4 for ACN?

Why were the RSUs granted to the reporting person?

What ownership does the Form 4 show after the transaction?

When was the Form 4 signed and by whom?

Does this Form 4 indicate a sale or open-market trade?

NYSE:ACN

ACN Rankings

ACN Latest News

ACN Latest SEC Filings

ACN Stock Data

AG真人官方

Trending News

[Form 4] Accenture PLC Insider Trading Activity

Insights

Securities Analyst neutral

Corporate Governance Expert neutral

FAQ

What did Paula A. Price report on the Form 4 for ACN?

Why were the RSUs granted to the reporting person?

What ownership does the Form 4 show after the transaction?

When was the Form 4 signed and by whom?

Does this Form 4 indicate a sale or open-market trade?

NYSE:ACN

ACN Rankings

ACN Latest News

ACN Latest SEC Filings

ACN Stock Data